Predicted protein targets (top 7)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | FABP4 | P15090 | 13/20 | 0.46 |
| ▸ | FABP3 | P05413 | 2/20 | 0.46 |
| ▸ | PTGDR | Q13258 | 6/20 | 0.43 |
| ▸ | TBXA2R | P21731 | 5/20 | 0.43 |
| ▸ | PTGER3 | P43115 | 1/20 | 0.41 |
| ▸ | PTGER2 | P43116 | 1/20 | 0.41 |
| ▸ | PTGIR | P43119 | 1/20 | 0.41 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL30317374 | 0.95 | TBXA2R (0.50) | FABP4FABP3PTGDRTBXA2R | |
| SCHEMBL28983434 | 0.95 | TBXA2R (0.50) | FABP4FABP3PTGDRTBXA2R | |
| SCHEMBL30317313 | 0.93 | FABP4 (0.45) | FABP4FABP3PTGDRTBXA2RPTGER3 | |
| SCHEMBL30317349 | 0.91 | FABP4 (0.43) | FABP4FABP3PTGDRTBXA2R | |
| SCHEMBL28983431 | 0.86 | TBXA2R (0.47) | FABP4FABP3PTGDRTBXA2R | |
| SCHEMBL30317342 | 0.85 | FABP4 (0.43) | FABP4FABP3PTGDRTBXA2R | |
| SCHEMBL30398050 | 0.85 | FABP4 (0.48) | FABP4FABP3PTGDRTBXA2R | |
| SCHEMBL24155323 | 0.85 | TBXA2R (0.46) | FABP4FABP3PTGDRTBXA2R | |
| SCHEMBL30317268 | 0.84 | FABP4 (0.63) | FABP4FABP3PTGDRTBXA2RPTGER3 | |
| SCHEMBL28983470 | 0.82 | FABP4 (0.57) | FABP4FABP3PTGDRTBXA2R |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 6 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-4175647-A1 | ANTIVIRAL USE OF FABP4 MODULATING COMPOUNDS | Crescenta Biosciences (US) | 2023-05-10 | — | — | EP | claimed |
| EP-4171736-A1 | NOVEL CELL METABOLISM MODULATING COMPOUNDS AND USES THEREOF | Crescenta Biosciences (US) | 2023-05-03 | — | — | EP | claimed |
| CN-115803085-A | Novel cell metabolism regulating compounds and uses | 新月生物科学 | 2023-03-14 | — | — | CN | claimed |
| EP-4175647-A1 | ANTIVIRAL USE OF FABP4 MODULATING COMPOUNDS | Crescenta Biosciences (US) | 2023-05-10 | — | — | EP | disclosed |
| EP-4171736-A1 | NOVEL CELL METABOLISM MODULATING COMPOUNDS AND USES THEREOF | Crescenta Biosciences (US) | 2023-05-03 | — | — | EP | disclosed |
| CN-115803085-A | Novel cell metabolism regulating compounds and uses | 新月生物科学 | 2023-03-14 | — | — | CN | disclosed |